191 related articles for article (PubMed ID: 34869703)
1. The Potential of ANGPTL8 Antagonism to Simultaneously Reduce Triglyceride and Increase HDL-Cholesterol Plasma Levels.
Zhang R
Front Cardiovasc Med; 2021; 8():795370. PubMed ID: 34869703
[TBL] [Abstract][Full Text] [Related]
2. Angiopoietin-like 3 inhibition of endothelial lipase is not modulated by angiopoietin-like 8.
Sylvers-Davie KL; Segura-Roman A; Salvi AM; Schache KJ; Davies BSJ
J Lipid Res; 2021; 62():100112. PubMed ID: 34461133
[TBL] [Abstract][Full Text] [Related]
3. Genetic Mimicry Analysis Reveals the Specific Lipases Targeted by the ANGPTL3-ANGPTL8 Complex and ANGPTL4.
Landfors F; Chorell E; Kersten S
J Lipid Res; 2023 Jan; 64(1):100313. PubMed ID: 36372100
[TBL] [Abstract][Full Text] [Related]
4. ANGPTL8 requires ANGPTL3 to inhibit lipoprotein lipase and plasma triglyceride clearance.
Haller JF; Mintah IJ; Shihanian LM; Stevis P; Buckler D; Alexa-Braun CA; Kleiner S; Banfi S; Cohen JC; Hobbs HH; Yancopoulos GD; Murphy AJ; Gusarova V; Gromada J
J Lipid Res; 2017 Jun; 58(6):1166-1173. PubMed ID: 28413163
[TBL] [Abstract][Full Text] [Related]
5. ANGPTL8 promotes the ability of ANGPTL3 to bind and inhibit lipoprotein lipase.
Chi X; Britt EC; Shows HW; Hjelmaas AJ; Shetty SK; Cushing EM; Li W; Dou A; Zhang R; Davies BSJ
Mol Metab; 2017 Oct; 6(10):1137-1149. PubMed ID: 29031715
[TBL] [Abstract][Full Text] [Related]
6. Relationship between Serum Angiopoietin-like Proteins 3 and 8 and Atherogenic Lipid Biomarkers in Non-Diabetic Adults Depends on Gender and Obesity.
Murawska K; Krintus M; Kuligowska-Prusinska M; Szternel L; Stefanska A; Sypniewska G
Nutrients; 2021 Nov; 13(12):. PubMed ID: 34959891
[TBL] [Abstract][Full Text] [Related]
7. An updated ANGPTL3-4-8 model as a mechanism of triglyceride partitioning between fat and oxidative tissues.
Zhang R; Zhang K
Prog Lipid Res; 2022 Jan; 85():101140. PubMed ID: 34793860
[TBL] [Abstract][Full Text] [Related]
8. Serum ANGPTL8 and ANGPTL3 as Predictors of Triglyceride Elevation in Adult Women.
Stefanska A; Bergmann K; Krintus M; Kuligowska-Prusinska M; Murawska K; Sypniewska G
Metabolites; 2022 Jun; 12(6):. PubMed ID: 35736472
[TBL] [Abstract][Full Text] [Related]
9. Association between ANGPTL3, 4, and 8 and lipid and glucose metabolism markers in patients with diabetes.
Harada M; Yamakawa T; Kashiwagi R; Ohira A; Sugiyama M; Sugiura Y; Kondo Y; Terauchi Y
PLoS One; 2021; 16(7):e0255147. PubMed ID: 34293055
[TBL] [Abstract][Full Text] [Related]
10. Angiopoietin-like protein 4 (ANGPTL4) is an inhibitor of endothelial lipase (EL) while the ANGPTL4/8 complex has reduced EL-inhibitory activity.
Chen YQ; Pottanat TG; Siegel RW; Ehsani M; Qian YW; Konrad RJ
Heliyon; 2021 Sep; 7(9):e07898. PubMed ID: 34504977
[TBL] [Abstract][Full Text] [Related]
11. ANGPTL3 and ANGPTL8 in Thai subjects with hyperalphalipoproteinemia and severe hypertriglyceridemia.
Kaewkrasaesin C; Chatchomchuan W; Muanpetch S; Khovidhunkit W
J Clin Lipidol; 2021; 15(5):752-759. PubMed ID: 34535418
[TBL] [Abstract][Full Text] [Related]
12. An anti-ANGPTL3/8 antibody decreases circulating triglycerides by binding to a LPL-inhibitory leucine zipper-like motif.
Balasubramaniam D; Schroeder O; Russell AM; Fitchett JR; Austin AK; Beyer TP; Chen YQ; Day JW; Ehsani M; Heng AR; Zhen EY; Davies J; Glaesner W; Jones BE; Siegel RW; Qian YW; Konrad RJ
J Lipid Res; 2022 May; 63(5):100198. PubMed ID: 35307397
[TBL] [Abstract][Full Text] [Related]
13. Angiopoietin-like protein 8: a multifaceted protein instrumental in regulating triglyceride metabolism.
Wen Y; Chen YQ; Konrad RJ
Curr Opin Lipidol; 2024 Apr; 35(2):58-65. PubMed ID: 37962908
[TBL] [Abstract][Full Text] [Related]
14. Atypical angiopoietin-like protein that regulates ANGPTL3.
Quagliarini F; Wang Y; Kozlitina J; Grishin NV; Hyde R; Boerwinkle E; Valenzuela DM; Murphy AJ; Cohen JC; Hobbs HH
Proc Natl Acad Sci U S A; 2012 Nov; 109(48):19751-6. PubMed ID: 23150577
[TBL] [Abstract][Full Text] [Related]
15. On the mechanism of angiopoietin-like protein 8 for control of lipoprotein lipase activity.
Kovrov O; Kristensen KK; Larsson E; Ploug M; Olivecrona G
J Lipid Res; 2019 Apr; 60(4):783-793. PubMed ID: 30686789
[TBL] [Abstract][Full Text] [Related]
16. The ANGPTL3-4-8 model, a molecular mechanism for triglyceride trafficking.
Zhang R
Open Biol; 2016 Apr; 6(4):150272. PubMed ID: 27053679
[TBL] [Abstract][Full Text] [Related]
17. Angiopoietin-like protein 8 differentially regulates ANGPTL3 and ANGPTL4 during postprandial partitioning of fatty acids.
Chen YQ; Pottanat TG; Siegel RW; Ehsani M; Qian YW; Zhen EY; Regmi A; Roell WC; Guo H; Luo MJ; Gimeno RE; Van't Hooft F; Konrad RJ
J Lipid Res; 2020 Aug; 61(8):1203-1220. PubMed ID: 32487544
[TBL] [Abstract][Full Text] [Related]
18. Correlation Between the Levels of ANGPTL3, ANGPTL4, ANGPTL8 and Postprandial Triglyceride-Rich Lipoprotein (TRL).
Zhang T; Hou Y; Liu M; Hou X; Tang Y; Ren L; Song G
Diabetes Metab Syndr Obes; 2023; 16():3979-3993. PubMed ID: 38084361
[TBL] [Abstract][Full Text] [Related]
19. ANGPTL3 blockade with a human monoclonal antibody reduces plasma lipids in dyslipidemic mice and monkeys.
Gusarova V; Alexa CA; Wang Y; Rafique A; Kim JH; Buckler D; Mintah IJ; Shihanian LM; Cohen JC; Hobbs HH; Xin Y; Valenzuela DM; Murphy AJ; Yancopoulos GD; Gromada J
J Lipid Res; 2015 Jul; 56(7):1308-17. PubMed ID: 25964512
[TBL] [Abstract][Full Text] [Related]
20. New insights into angiopoietin-like proteins in lipid metabolism and cardiovascular disease risk.
Kersten S
Curr Opin Lipidol; 2019 Jun; 30(3):205-211. PubMed ID: 30893111
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
